Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Núcleo de Pesquisa Clínica e Bioequivalência (NUPEB) is a specialized Brazilian Contract Research Organization (CRO) providing clinical and analytical services to the pharmaceutical industry. Established in 2002 and headquartered in Araraquara, São Paulo, the company primarily conducts bioequivalence and relative bioavailability studies essential for the registration of generic and similar medicines. NUPEB's facilities include a dedicated clinical unit for volunteer confinement and a high-tech bioanalytical laboratory equipped with LC-MS/MS instrumentation. The organization operates in strict compliance with Good Clinical Practice (GCP) and Good Laboratory Practice (GLP) standards, holding necessary certifications from ANVISA. Beyond bioequivalence, NUPEB offers support for Phase I clinical trials and pharmacokinetic modeling, positioning itself as a key partner for drug development in the Latin American market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Núcleo de Pesquisa Clínica e Bioequivalência.